期刊文献+

γ射线对大鼠血管平滑肌细胞增殖和周期影响 被引量:3

Inhibitory effect ofγ-ray irradiation on rat vascular smooth muscle cells
原文传递
导出
摘要 目的 探讨γ射线对大鼠血管平滑肌细胞 (VSMCs)抑制作用的机理。方法 对大鼠VSMCs进行原代培养 ,经3H TdR掺入法观察γ射线对VSMCs增殖情况的影响。应用流式细胞仪检测γ射线对VSMCs细胞周期的影响。采用WesternBlot技术检测γ射线对VSMCsp53、细胞周期素D(cy clinD)和增殖细胞核抗原 (PCNA)表达的影响。结果 γ射线对VSMCs增殖的抑制作用呈剂量依赖性。γ射线照射可诱导VSMCs出现G1 期阻滞 ,在照射后一定时间内会导致p53表达增强 ,cyclinD和PCNA表达减弱。结论 γ射线可抑制VSMCs增殖 ,其机制可能主要是γ射线诱导VSMCs出现G1 期阻滞 ,抑制VSMCs进行有丝分裂。在这个过程中p53。 Objective To investigate the mechanism of the inhibitory effect of γ-ray irradiation on rat vascular smooth muscle cells(VSMC). Methods The ef fect of γ-ray irradiation on proliferation of VSMC was observed by 3?H-TdR incor poration. After γ-ray irradiation, the VSMC cell cycle change was detected b y flo w cytometry. The expression of p53, cyclin D and PCNA was investigated by Wester n Blot. Results The inhibitory effect of γ-ray irradiation on VSMC proliferati on was dose-dependent. After γ-ray irradiation, VSMC was arrested in G 1 st age, w ith the expression of p53 increased but the expression of cyclin D and PCNA decr eased. Conclusions γ-ray irradiation can inhibit the proliferation of VSMC. T he main mechanism is probably due to the induction of cell cycle arrest and inhi bition of the VSMC mitosis ,during which process, p53,cyclin D and PCNA all pla y an important role .
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2003年第1期50-53,共4页 Chinese Journal of Radiation Oncology
基金 国家自然基金资助项目 ( 3990 0 16 7)
关键词 血管平滑肌细胞 培养的 Γ射线 细胞周期 基因表达 大鼠 Vascular smooth muscle cells γ-ray Cell cycle Gene expression Rat
  • 相关文献

同被引文献36

  • 1姜萍.60例老年性前列腺增生症X线立体定向放射治疗研究[J].中国医药指南,2008,6(16):457-458. 被引量:4
  • 2余小平,张斌,曲环,杨海涛,王纯,董会奕.放射治疗支架内再狭窄诱导平滑肌细胞凋亡的分子机制[J].中国老年学杂志,2006,26(5):644-646. 被引量:2
  • 3Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reeonstr Surg, 2001 ; 107 ( 1 ) :87--96.
  • 4Mancini T, Porcelfi T, Giustina A. Treatment of cushing disease : overview and recent findings. Ther Clin Risk Manag, 2010;21;6: 505-516.
  • 5Steele C A, MacFarlane I A, Blair J, et al. Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes. Eur J Endocrinol, 2010; 163 (4) :515-522.
  • 6Claus S. Berges R. Scngn Schulze H. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J Urology, 1997, 158: 217-221.
  • 7Abrams P, Cardozo L, Fall M, et al. ogy of lower urinary tract function: Sub-Committee of the International The standardisation of terminol- report from the Standardisation Continence Society. Neurourol Urodyn 2002 ;21:167-178.
  • 8Mark J. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) : more than treating symptoms? European Urology, 2008 ; ( supplements 7 ) :680-689.
  • 9Michel M, de la Rosette J. Medical treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. European Urology ,2009 ; ( supplements 8 ) :496-503.
  • 10Mianol R, De Nunzio C, Asimakopoulos A D. ,et al. Treatment options for benign prostatic hyperplasia in older men. Med Sci Monit, 2008 ; 14 (7) : RA94-102.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部